Medicine & Life Sciences
Parkinson Disease
100%
Parkinsonian Disorders
53%
Stroke
29%
Arteriovenous Malformations
27%
Progressive Supranuclear Palsy
26%
Systematic Reviews
26%
Scotland
24%
Multiple System Atrophy
19%
Confidence Intervals
18%
Levodopa
17%
Disease Progression
15%
Population
15%
Multiple Sclerosis
15%
Monoamine Oxidase Inhibitors
14%
Dopamine Agonists
13%
Monoamine Oxidase
13%
Mental Status and Dementia Tests
13%
Brain
12%
Conservative Treatment
12%
Glatiramer Acetate
12%
Intracranial Hemorrhages
11%
Dementia
11%
Therapeutics
11%
Incidence
10%
Odds Ratio
10%
Parkinson Disease, Familial, Type 1
10%
Hemorrhage
10%
ocrelizumab
10%
Randomized Controlled Trials
9%
Interferon-beta
9%
Cohort Studies
9%
Clinical Trials
8%
Central Nervous System Cavernous Hemangioma
8%
Seizures
8%
propylene diquat
8%
Network Meta-Analysis
8%
Anticoagulants
8%
Chronic Progressive Multiple Sclerosis
8%
Glucosylceramidase
8%
Activities of Daily Living
7%
Infectious Mononucleosis
7%
Mortality
7%
Survival
7%
Dopamine Agents
7%
Quality of Life
6%
Vascular Malformations
6%
National Institutes of Health (U.S.)
6%
Alzheimer Disease
6%
Health Care Outcome Assessment
6%
Cognitive Dysfunction
6%
Social Sciences
multiple sclerosis
11%
dementia
6%